Abstract:Objective: To assess the incidence, risk factors and clinical presentations of neonatal adrenal haemorrhage (NAH) in uncomplicated, singleton and term deliveries. Methods: A retrospective analysis of 26 416 term neonates delivered between 2001 and 2013, and screened with abdominal ultrasonography. Results: Of the 26 416 neonates, 74 (0.28%) displayed NAH; the male/female ratio was 1.55:1. Vaginal delivery was significantly more frequent than caesarean section among them (71 versus 3; 95.9% versus 4.1%). Unilat… Show more
“…However, persistent neonatal jaundice, flank mass, scrotal swelling and haematuria, anaemia, hypo or hypertension, cyanosis, urinary tract infections and may be adrenal insufficiency with shock. The most common presentation includes neonatal jaundice, due to the breakdown of red blood cells in the hematoma [1,[5][6][7][15][16][17][18][21][22][23][24][25][26][27][28][29][30][31]. The nature of adrenal haemorrhage, in this series was bilateral.…”
Section: Discussionmentioning
confidence: 99%
“…This is highly vascular supply drains into medullary sinusoids via relatively few venous channels, thereby creating a potential vascular damage. Any condition leading to reduce oxygen supply (hypoxia) may lead to shunting of blood flow, and damage to endothelial making them more prone to haemorrhage, an example of this is congenital adrenal hyperplasia [1][2][3][16][17][18][19][20][21][22][23][24][25][26][27][28][29]. The most important predisposing cause of AH were birth trauma, prolonged labour, intrauterine infections, perinatal asphyxia or hypoxia, large birth weight, septicaemia, and haemorrhagic disorders.…”
Background: Adrenal haemorrhage (AH) in the new-born is not that uncommon and has been reported frequently. AH occurs most often after a traumatic delivery or complicated neonatal course. Design and setting: A retrospective, hospital-based study conducted at king Khalid university hospital (KKUH), endocrine service, Riyadh, Saudi Arabia, during the period January 2014 and July 2018. Methods: Medical records of neonates who had been diagnosed to have AH were reviewed. Data included age, sex, clinical manifestations, laboratory and radiological investigations. Results: During the period under review, five neonates were diagnosed to have adrenal haemorrhage. All were term male infants, who were delivered vaginally .one baby was large for gestational age (LGA), and three babies had perinatal hypoxemia. Clinical symptoms were not specific and diagnosis was confirmed by performing abdominal sonography (USG). Conclusion: AH should be recognised in the new-borns with nonspecific symptoms who had potential risk factors. Abdominal ultrasonography (USG) should be performed to diagnose AH, and monitor its progress. Adrenal hormone testing also should be performed.
“…However, persistent neonatal jaundice, flank mass, scrotal swelling and haematuria, anaemia, hypo or hypertension, cyanosis, urinary tract infections and may be adrenal insufficiency with shock. The most common presentation includes neonatal jaundice, due to the breakdown of red blood cells in the hematoma [1,[5][6][7][15][16][17][18][21][22][23][24][25][26][27][28][29][30][31]. The nature of adrenal haemorrhage, in this series was bilateral.…”
Section: Discussionmentioning
confidence: 99%
“…This is highly vascular supply drains into medullary sinusoids via relatively few venous channels, thereby creating a potential vascular damage. Any condition leading to reduce oxygen supply (hypoxia) may lead to shunting of blood flow, and damage to endothelial making them more prone to haemorrhage, an example of this is congenital adrenal hyperplasia [1][2][3][16][17][18][19][20][21][22][23][24][25][26][27][28][29]. The most important predisposing cause of AH were birth trauma, prolonged labour, intrauterine infections, perinatal asphyxia or hypoxia, large birth weight, septicaemia, and haemorrhagic disorders.…”
Background: Adrenal haemorrhage (AH) in the new-born is not that uncommon and has been reported frequently. AH occurs most often after a traumatic delivery or complicated neonatal course. Design and setting: A retrospective, hospital-based study conducted at king Khalid university hospital (KKUH), endocrine service, Riyadh, Saudi Arabia, during the period January 2014 and July 2018. Methods: Medical records of neonates who had been diagnosed to have AH were reviewed. Data included age, sex, clinical manifestations, laboratory and radiological investigations. Results: During the period under review, five neonates were diagnosed to have adrenal haemorrhage. All were term male infants, who were delivered vaginally .one baby was large for gestational age (LGA), and three babies had perinatal hypoxemia. Clinical symptoms were not specific and diagnosis was confirmed by performing abdominal sonography (USG). Conclusion: AH should be recognised in the new-borns with nonspecific symptoms who had potential risk factors. Abdominal ultrasonography (USG) should be performed to diagnose AH, and monitor its progress. Adrenal hormone testing also should be performed.
“…4 NAH is more common in term infants, and is associated with vaginal delivery, macrosomia, fetal acidemia, hypoxia, birth asphyxia, sepsis, coagulation disorders, hypothrombinemia, prolonged labor, traumatic delivery, and perinatal injuries. 2 All three infants reported here were macrosomic and born at term by vaginal delivery. The first and second ones showed clear signs of birth asphyxia due to a difficult and traumatic birth, whereas the third one was completely asymptomatic at birth.…”
Neonatal adrenal hemorrhage (NAH) in newborn infants is a rare event that is associated with specific anatomical and vascular characteristics. It is more common in term infants and occurs more often in neonates who feature perinatal asphyxia. Symptoms that more frequently prompt to diagnosis are prolonged jaundice, detection of an abdominal mass, anemia, scrotal discoloration and/or swelling, hypotonia, lethargy, and hypertension. However, NAH may also occur without symptoms with its detection being occasional. Imaging through ultrasound scans is the cornerstone of diagnosis and follow-up monitoring over time. Here we report on a small NAH case series comprising three full-term, macrosomic infants who were born by vaginal delivery. The first and second ones showed clear signs of birth asphyxia, whereas the third was completely asymptomatic. In all three patients, only the right adrenal gland was involved, in line with what happens in 70% of cases. NAH is usually self-limiting and prone to a progressive resolution in a time ranging between 3 weeks and 6 months and so did in our three patients.
Key Points
“…AH is not infrequent in neonates suffering fetal distress during difficult labor with perinatal hypoxia . An association between AH and RVT has been reported.…”
EKT from neonatal donors remains rare despite successful outcome being reported. The surgical aspects of neonatal abdominal organ recovery remain unfamiliar to the vast majority of abdominal organ recovery teams and renal transplant surgeons. BAH is not uncommon in newborn babies suffering distress in the perinatal period. BAH is often also associated with RVT and will impact on utilization of kidneys for transplantation. We present a case of a neonatal kidney donor with massive BAHs discovered at the time of organ recovery. This made the procurement challenging. Both kidneys were recovered en bloc with pancreas and the liver with aorta and inferior vena cave as vascular conduits. The kidneys were successfully implanted into an adult recipient with good function at 1-year follow-up. Association between adrenal hemorrhage and RVT needs to be considered before utilizing such kidneys. This case exemplifies successful outcome after careful assessment and transplantation of such kidneys.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.